Healthcare & Life Sciences

Sab Biotherapeutics

Sign in to unlock

About

Develops a platform to generate fully-human antibody therapies with improved safety and pharmacological properties for treating autoimmune and infectious diseases.

Explore Sab Biotherapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing